Bank of New York Mellon »

Miragen Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.7M 152k 17.51
2023-12-31 $3.3M 150k 21.78
2023-09-30 $2.1M 138k 15.34
2023-06-30 $3.4M 142k 23.79
2023-03-31 $3.6M 140k 25.44
2022-12-31 $4.5M 153k 29.21
2022-09-30 $1.8M 90k 20.49
2022-06-30 $804k 69k 11.60